GlassScriptPhysician profile
Neel Naresh Patel
NPI 1083096374
$1,207.88
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $20.47 · 2022: $21.56 · 2023: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $330 · Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $330.00 |
| Food and Beverage | $149.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $330.00 | 2023 | Acell |
| Medtronic USA, INC. | $178.27 | 2019 | |
| Si-Bone, INC. | $149.73 | 2023 | |
| Abbott Laboratories | $146.05 | 2019 | |
| Greenwich Biosciences, INC. | $144.31 | 2019 | |
| Sunovion Pharmaceuticals INC. | $125.21 | 2019 | |
| Eisai INC. | $42.51 | 2019-2020 | |
| Genentech USA, INC. | $21.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.56 | 2022 | |
| Neurocrine Biosciences, INC. | $18.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.38 | 2019 | |
| Allergan, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.